Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $6.65 million. The enterprise value is $10.67 million.
| Market Cap | 6.65M |
| Enterprise Value | 10.67M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, after market close.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.93 million shares outstanding. The number of shares has decreased by -8.42% in one year.
| Current Share Class | 1.93M |
| Shares Outstanding | 1.93M |
| Shares Change (YoY) | -8.42% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 3.55% |
| Owned by Institutions (%) | 18.70% |
| Float | 1.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| Forward PS | 9.88 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.61, with a Debt / Equity ratio of 1.71.
| Current Ratio | 2.61 |
| Quick Ratio | 2.24 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -111.65% and return on invested capital (ROIC) is -36.59%.
| Return on Equity (ROE) | -111.65% |
| Return on Assets (ROA) | -30.73% |
| Return on Invested Capital (ROIC) | -36.59% |
| Return on Capital Employed (ROCE) | -87.68% |
| Weighted Average Cost of Capital (WACC) | 2.53% |
| Revenue Per Employee | $204,348 |
| Profits Per Employee | -$1.25M |
| Employee Count | 23 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.05% in the last 52 weeks. The beta is 1.09, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -39.05% |
| 50-Day Moving Average | 3.73 |
| 200-Day Moving Average | 4.59 |
| Relative Strength Index (RSI) | 42.87 |
| Average Volume (20 Days) | 37,645 |
Short Selling Information
The latest short interest is 18,486, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 18,486 |
| Short Previous Month | 15,579 |
| Short % of Shares Out | 0.96% |
| Short % of Float | 1.14% |
| Short Ratio (days to cover) | 0.77 |
Income Statement
In the last 12 months, BOLT had revenue of $4.70 million and -$28.74 million in losses. Loss per share was -$16.38.
| Revenue | 4.70M |
| Gross Profit | -16.80M |
| Operating Income | -28.48M |
| Pretax Income | -28.74M |
| Net Income | -28.74M |
| EBITDA | -27.56M |
| EBIT | -28.48M |
| Loss Per Share | -$16.38 |
Balance Sheet
The company has $17.60 million in cash and $21.62 million in debt, with a net cash position of -$4.03 million or -$2.09 per share.
| Cash & Cash Equivalents | 17.60M |
| Total Debt | 21.62M |
| Net Cash | -4.03M |
| Net Cash Per Share | -$2.09 |
| Equity (Book Value) | 12.64M |
| Book Value Per Share | 6.56 |
| Working Capital | 12.70M |
Cash Flow
In the last 12 months, operating cash flow was -$31.45 million and capital expenditures -$85,000, giving a free cash flow of -$31.54 million.
| Operating Cash Flow | -31.45M |
| Capital Expenditures | -85,000 |
| Depreciation & Amortization | 919,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -31.54M |
| FCF Per Share | -$16.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | -605.85% |
| Pretax Margin | -611.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 8.42% |
| Shareholder Yield | 8.42% |
| Earnings Yield | -404.31% |
| FCF Yield | -443.66% |
Analyst Forecast
The average price target for BOLT is $29.00, which is 740.58% higher than the current price. The consensus rating is "Buy".
| Price Target | $29.00 |
| Price Target Difference | 740.58% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 1.30% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
BOLT has an Altman Z-Score of -18.13 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -18.13 |
| Piotroski F-Score | 2 |